Nadia Fairbairn (N Fairbairn)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Antiretroviral Therapy

Cross Sectional

Hiv Infected Patients

Top Venues

Drug and alcohol review

JMIR medical education

Substance use & misuse

This page only lists publications with an associated author ORCID identifier.

Publications

Jenna Langlois, Nadia Fairbairn, Didier Jutras-Aswad, Bernard Le Foll, Ron Lim, Maria Eugenia Sociás
Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada. Drug and alcohol review (2024)
Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, Bernard Le Foll, Rupi Brar, Christy Sutherland, Nadia Fairbairn
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19. Harm reduction journal 19 (1) (2022)
Jan Klimas, Lauren Renee Gorfinkel, Michee-Ana Hamilton, M Lail, D Krupchanka, Walter Cullen, Evan Wood, Nadia Fairbairn
Early Career Training in Addiction Medicine: A Qualitative Study with Health Professions Trainees Following a Specialized Training Program in a Canadian Setting. Substance use & misuse 57 (14) (2022)
Jan Klimas, Huiru Dong, Michee-Ana Hamilton, Walter Cullen, Jeffrey H Samet, Evan Wood, Nadia Fairbairn
Impact of the international collaborative addiction medicine research fellowship on physicians' future engagement in addiction research. Substance abuse 43 (1) (2022)
Rupinder Brar, Nadia Fairbairn, Christy Sutherland, Seonaid Nolan
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case series. Drug and alcohol review 39 (5) (2021)
Daniel Shearer, Samantha Young, Nadia Fairbairn, Rupinder Brar
Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case series. Drug and alcohol review (2021)
Kanna Hayashi PhD, Evan Wood, Huiru Dong, Jane A Buxton, Nadia Fairbairn, Hudson Reddon, Michael John Milloy, Thomas Kerr
Awareness of fentanyl exposure and the associated overdose risks among people who inject drugs in a Canadian setting. Drug and alcohol review 40 (6) (2021)
Soroush Moallef, Ekaterina Nosova, Seonaid Nolan, Nadia Fairbairn, Jane Loh, Kanna Hayashi PhD, M-J Milloy
Prevalence and longitudinal correlates of recent exposure to fentanyl among HIV-positive people who use unregulated drugs during a community-wide overdose crisis. AIDS care 33 (12) (2021)
Claire Ronsley, Seonaid Nolan, Rod Knight, Kanna Hayashi, Jano Klimas, Alex Walley, Evan Wood, Nadia Fairbairn
Treatment of stimulant use disorder: A systematic review of reviews. PloS one 15 (6) (2020)
S Ickowicz, H Dong, L Ti, S Nolan, Nadia Fairbairn, R Barrios, M-J Milloy
Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017. AIDS care 32 (10) (2020)
Rupinder Brar, Cameron J Grant, Kora DeBeck, Michael John Milloy, Nadia Fairbairn, Evan Wood, Thomas Kerr, Kanna Hayashi PhD
Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada. The American journal of drug and alcohol abuse 46 (5) (2020)
Lauren Renee Gorfinkel, Amanda Giesler, Huiru Dong, Evan Wood, Nadia Fairbairn, Jan Klimas
Development and Evaluation of the Online Addiction Medicine Certificate: Free Novel Program in a Canadian Setting. JMIR medical education 5 (1) (2019)
Samantha Young, Nadia Fairbairn
Expanding supervised injection facilities across Canada: lessons from the Vancouver experience. Canadian journal of public health = Revue canadienne de sante publique 109 (2) (2018)